A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma: Correspondence

British Journal of Haematology

Volumn 150, Issue 3, 2010, Pages 371-373

  Pratt, Guy ^a   Fenton, James A L ^b   Allsup, David ^c   Fegan, Chris ^d   Morgan, Gareth J ^e   Jackson, Graham ^f   Sunter, Nicola J ^g   Hall, Andrew G ^g   Irving, Julie A E ^g   Allan, James M ^g  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

^d CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f ROYAL VICTORIA INFIRMARY   (United Kingdom)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

MGUS; molecular genetics; myeloma

Indexed keywords

3' UNTRANSLATED REGION; AGED; ALLELE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; FEMALE; GENE; GENE MAPPING; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IRF4 GENE; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HODGKIN DISEASE; HUMANS; INTERFERON REGULATORY FACTORS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954579784     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08199.x     Document Type: Letter

References (10)

1. Allan, J.M., Sunter, N.J., Bailey, J.R., Pettitt, A.R., Harris, R.J., Pepper, C., Fegan, C., Hall, A.G., Deignan, L., Bacon, C.M., Pointon, J.C., Houlston, R.S., Broderick, P., Mainou-Fowler, T., Jackson, G.H., Summerfield, G., Evans, P.A., Strefford, J.C., Parker, A., Oscier, D., Pratt, G. Allsup, D. (2010) Variant IRF4 associates with CD38 status and treatment-free survival in chronic lymphocytic leukemia. Leukemia, doi: 10,1038/leu.2009.298
2. Broderick, P., Cunningham, D., Vijayakrishnan, J., Cooke, R., Ashworth, A., Swerdlow, A. Houlston, R.S. (2010) IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma. British Journal of Haematology, 148, 413 415.
3. Busslinger, M. (2004) Transcriptional control of early B-cell development. Annual Review of Immunology, 22, 55 79.
4. Di Bernardo, M.C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A.M., Sunter, N.J., Hall, A.G., Dyer, M., Matutes, E., Dearden, C., Mainou-Fowler, T., Jackson, G.H., Summerfield, G., Harris, R.J., Pettitt, A.R., Hillmen, P., Allsup, D.J., Bailey, J.R., Pratt, G., Pepper, C., Fegan, C., Allan, J.M., Catovsky, D. Houlston, R.S. (2008) A genome-wide association study identifies chronic lymphocytic leukemia susceptibility loci at 2q13, 2q37.1 (SP140), 6p25.3 (IRF4/MUM1), 11q24.1, 15q23, and 19q13.32 (PRKD2). Nature Genetics, 40, 1204 1210.
5. Do, T.N., Ucisik-Akkaya, E., Davis, C.F., Morrison, B.A. Dorak, M.T. (2010) An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochimica et Biophysica Acta, 1802, 292 300.
6. Gathany, A.H., Hartge, P., Davis, S., Cerhan, J.R., Severson, R.K., Cozen, W., Rothman, N., Chanock, S.J. Wang, S.S. (2010) Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes and Control, doi: http://dx.doi.org/10.1007/s10552-009-9348-5.
7. Heintel, D., Zojer, N., Schreder, M., Strasser-Weippl, K., Kainz, B., Vesely, M., Gisslinger, H., Drach, J., Gaiger, A., Jäger, U. Ludwig, H. (2008) Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma. Leukemia, 22, 441 445.
8. Kane, E.V., Roman, E., Cartwright, R., Parker, J. Morgan, G. (1999) Tobacco and the risk of acute leukaemia in adults. British Journal of Cancer, 81, 1228 1233.
9. Klein, U. Della-Favera, R. (2007) Unexpected steps in plasma cell differentiation. Immunity, 26, 543 544.
10. Shaffer, A.L., Emre, N.C., Lamy, L., Ngo, V.N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., Zeng, Y., Chen, B., Epstein, J. Staudt, L.M. (2008) IRF4 addicition in multiple myeloma. Nature, 454, 226 231.